Amdocs Limited
NASDAQAmdocs reported fiscal Q2 results just hours ago, and the setup is a familiar one for this stock: a clean beat followed by guidance that asks more patience of investors than many are willing to give. Revenue came in at $1.17 billion, fractionally above estimates, and adjusted EPS of $1.78 beat the $1.76 consensus. The full-year EPS range was narrowed to $7.34–$7.48 versus the prior…
Snapshot as of 28 Jun 2026
Amdocs reported fiscal Q2 results just hours ago, and the setup is a familiar one for this stock: a clean beat followed by guidance that asks more patience of investors than many are willing to give. Revenue came in at…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for DOX — free to start on ORTEX.
Sign up for free →Open DOX on ORTEX